Biotechnology Apellis Announces Detailed 18-Month Results from Phase 3 DERBY and OAKS Studies of Pegcetacoplan for Geographic Atrophy (GA) at ARVO Annual Meeting May 2, 2022
Tech EVBG INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Everbridge, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EVBG May 2, 2022
Biotechnology Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Should You Buy? May 2, 2022
Biotechnology Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? May 2, 2022